BTN1A1 is a novel immune checkpoint mutually exclusive to PD-L1

BTN1A1 is a novel immune checkpoint mutually exclusive to PD-L1

Background While Programmed cell death protein 1 (PD-1)/programmed cell death-ligand 1 (PD-L1) blockade is a potent antitumor treatment strategy, it is effective in only limited subsets of patients with cancer, emphasizing the need for the identification of additional immune checkpoints. Butyrophili...

Full description

Saved in:
Bibliographic Details
Main Authors: Young-Seung Kim, Bong-Ki Hong, Steven H Lin, Seung-Hoon Lee, Stephen S Yoo, Chunai Wu, Andrew H Park, Hyunjin Jung
Format: Article
Language:English
Published: BMJ Publishing Group 2024-03-01
Series:Journal for ImmunoTherapy of Cancer
Online Access:https://jitc.bmj.com/content/12/3/e008303.full
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items